Health Care M&A Weekly Deals, The Week Ending February 23, 2018

Health Care M&A Weekly Deals, The Week Ending February 23, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Merck Viralytics Limited $394 million BenevolentAI Cambridge Research Campus N/A Kite Pharma License to zinc finger nuclease technology $150 million eHealth Acquirer Target Price TractManager, Inc.... Read More »
Health Care M&A Weekly Deals, The Week Ending February 23, 2018

Health Care M&A Weekly Deals, The Week Ending February 16, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Bioverativ Inc. License to lentiviral vectors $5 million Oncologie, Inc. Exclusive license to lefitolimod $369 million Lee’s Pharmaceutical Limited Exclusive rights to GCC-4401C N/A Bristol-Myers... Read More »
Q4:2017 Health Care Spending, by Sector and Share

Q4:2017 Health Care Spending, by Sector and Share

A total of $114.4 billion was spent to fund the 377 transactions reported in Q4:17, based on disclosed prices. The Managed Care sector dominated the dollar side of deal making, accounting for 70% ($80.6 billion) of spending. A single deal accounted for 67% of the quarter’s total, as CVS Health (NYSE: CVS) announced its agreement to acquire Aetna Inc. (NYSE: AET) for $77.0 billion (including debt). If that deal doesn’t close, this chart will look very different. The rest of the healthcare sectors were relegated to single-digit shares of the fourth quarter’s spending pie. The Pharmaceutical sector contributed 6% of the quarter’s total, with $6.9 billion, followed by Biotechnology (5%... Read More »

Health Care M&A Weekly Deals, The Week Ending February 9, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Roivant Sciences Exclusive license to derazantinib $3 million eHealth Acquirer Target Price Varian Medical Systems, Inc. Mobius Medical Systems N/A Pamlico Capital Office Practicum N/A Home Health Care... Read More »

Health Care M&A Weekly Deals, The Week Ending February 2, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Transitions, Inc. Drug and alcohol treatment center N/A Biotechnology Acquirer Target Price Shire plc Global license to PRIM program N/A Medison Pharma, Ltd. License to Nerlynx in Israel N/A... Read More »

Health Care M&A Weekly Deals, The Week Ending January 26, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Pharos Capital Group, LLC Behavior Care Specialists N/A Biotechnology Acquirer Target Price Biogen Inc. KPT-350 $10 million DanDrit Biotech USA, Inc. Enochian Biopharma Inc. N/A Celgene... Read More »